CoChat

The DOI matches its Crossref record; 68 of the 69 references it cites were found in a registry or an index.

Randomized controlled experimental study of hydrocortisone and D-cycloserine effects on fear extinction in PTSD

Open access

Abstract

Fear extinction underlies prolonged exposure, one of the most well-studied treatments for posttraumatic stress disorder (PTSD). There has been increased interest in exploring pharmacological agents to enhance fear extinction learning in humans and their potential as adjuncts to PE. The objective of such adjuncts is to augment the clinical impact of PE on the durability and magnitude of symptom reduction. In this study, we examined whether hydrocortisone (HC), a corticosteroid, and D-Cycloserine (DCS), an N-methyl-D-aspartate receptor partial agonist, enhance fear extinction learning and consolidation in individuals with PTSD. In a double-blind placebo-controlled 3-group experimental design, 90 individuals with full or subsyndromal PTSD underwent fear conditioning with stimuli that were paired (CS+) or unpaired (CS−) with shock. Extinction learning occurred 72 h later and extinction retention was tested one week after extinction. HC 25 mg, DCS 50 mg or placebo was administered one hour prior to extinction learning. During extinction learning, the DCS and HC groups showed a reduced differential CS+/CS− skin conductance response (SCR) compared to placebo (b = −0.19, CI = −0.01 to −37, p = 0.042 and b = −0.25, CI = −08 to −0.43, p = 0.005, respectively). A nonsignificant trend for a lower differential CS+/CS− SCR in the DCS group, compared to placebo, (b = −0.25, CI = 0.04 to −0.55, p = 0.089) was observed at retention testing, one week later. A single dose of HC and DCS facilitated fear extinction learning in participants with PTSD symptoms. While clinical implications have yet to be determined, our findings suggest that glucocorticoids and NMDA agonists hold promise for facilitating extinction learning in PTSD.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41386-021-01222-z

Cites

68 of 68 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Timeline of study procedures. Psychophysiological testing occurred over 3 sessions. These included: Session 1: Habituation and fear conditioning. Session 2: Drug administration and fear extinction learning. Session 2 was scheduled 72 h following fear conditioning. A single dose of HC 25 mg, DCS 50 mg or placebo was administered 1 hr prior to extinction learning. Session 3: Extinction retention was tested 1 week after extinction learning.
Fig. 1 Timeline of study procedures. Psychophysiological testing occurred over 3 sessions. These included: Session 1: Habituation and fear conditioning. Session 2: Drug administration and fear extinction learning. Session 2 was scheduled 72 h following fear conditioning. A single dose of HC 25 mg, DCS 50 mg or placebo was administered 1 hr prior to extinction learning. Session 3: Extinction retention was tested 1 week after extinction learning.CC BY · PubMed Central
Fig. 2 All study trials by group. Group mean skin conductance response scores for the conditioned stimulus (CS) intervals of CS+ and CS− trials during habituation, fear conditioning, extinction learning, and extinction retention. Data was converted to z scores to correct for variability in each participant’s range of responses.
Fig. 2 All study trials by group. Group mean skin conductance response scores for the conditioned stimulus (CS) intervals of CS+ and CS− trials during habituation, fear conditioning, extinction learning, and extinction retention. Data was converted to z scores to correct for variability in each participant’s range of responses.CC BY · PubMed Central
Fig. 3 CS+/CS− difference for extinction learning and retention by group. CS+/CS− difference for early and late extinction (first 5 CS+ and 5 CS− trials and second 5 CS+ and 5 CS− trials) and retention (first 4 CS+ and 4 CS− trials) by group: Differential scores (CS+ minus CS−) for the conditioned stimulus (CS) intervals during the extinction learning and retention phases for each drug condition. Plotted values are marginal effects from the mixed models.
Fig. 3 CS+/CS− difference for extinction learning and retention by group. CS+/CS− difference for early and late extinction (first 5 CS+ and 5 CS− trials and second 5 CS+ and 5 CS− trials) and retention (first 4 CS+ and 4 CS− trials) by group: Differential scores (CS+ minus CS−) for the conditioned stimulus (CS) intervals during the extinction learning and retention phases for each drug condition. Plotted values are marginal effects from the mixed models.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 69 references

Research works printed but not linked: 1

  1. First MB, Spitzer RL, Gibbon M, Williams JBW. Structured clinical interview for DSM-IV Axis I disorders, research version, non-patient edition. (SCID-I/NP). Biometrics Research, New York State Psychiatric Institute: New York; 2002.

Cited by

See all 49

Metadata

Authors
Inslicht, S. S., Niles, A. N., Metzler, T. J., Lipshitz, S. L., Otte, C., Milad, M. R., Orr, S. P., Marmar, C. R., & Neylan, T. C.
Affiliations
  • University of California, San Francisco (US)
  • San Francisco VA Health Care System (US)
  • New York University (US)
  • Harvard University (US)
Corresponding author
Inslicht, Sabra S.
Venue
Neuropsychopharmacology
Published
2021-11-19
Volume
47
Issue
11
Pages
1945-1952
ISSN
  • 0893-133X (ISSN-L)
  • 1740-634X
OpenAlex
W3212275176
Cited by
44
References
69
Citations by year
2026: 7 · 2025: 7 · 2024: 6 · 2023: 16 · 2022: 8
FWCI
5.12
Type
journal article
Language
en
Open access
Licence
Locations
  • Neuropsychopharmacology (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • eScholarship (California Digital Library) (submittedVersion, cc-by)
Funders
  • McCormick Foundation
  • U.S. Department of Veterans Affairs (I01 CX000720)
  • Charles H. Hood Foundation
  • Robin Hood Foundation
  • Jazz Pharmaceuticals
  • Sage Therapeutics
  • Steven and Alexandra Cohen Foundation
  • Cohen Veterans Bioscience
  • European Commission (IMI2 859366)
  • Deutsche Forschungsgemeinschaft (EXC 2049)
  • Bundesministerium für Bildung und Forschung (KS2017-067)
  • Eisai
  • Otsuka Pharmaceutical
  • H. Lundbeck A/S
  • Berlin Institute of Health (B3010350)
  • National Institutes of Health (RR024130)
  • University of California, San Francisco
  • NIH Office of the Director
  • National Center for Research Resources (KL2RR024130, RR-024130)
  • NIH Clinical Center
  • National Center for Advancing Translational Sciences
Topics
  • Social Sciences › Psychology › Clinical Psychology › Posttraumatic Stress Disorder Research
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Memory and Neural Mechanisms
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Memory Processes and Influences
Keywords
post-traumatic stress disorder, fear extinction, cortisol, D-cycloserine, prolonged exposure therapy, fear conditioning, skin conductance response, glucocorticoids, NMDA receptor partial agonist, drug augmentation, extinction consolidation
MeSH terms
Cycloserine, Double-Blind Method, Extinction, Psychological, Fear, Glucocorticoids, Humans, Hydrocortisone, Stress Disorders, Post-Traumatic, Receptors, N-Methyl-D-Aspartate, N-Methylaspartate

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Randomized controlled experimental study of hydrocortisone and D-cycloserine effects on fear extinction in PTSD. https://app.cochat.ai/papers/10.1038/s41386-021-01222-z
The paper
Inslicht, S. S., Niles, A. N., Metzler, T. J., Lipshitz, S. L., Otte, C., Milad, M. R., Orr, S. P., Marmar, C. R., & Neylan, T. C. (2022). Randomized controlled experimental study of hydrocortisone and D-cycloserine effects on fear extinction in PTSD. Neuropsychopharmacology. https://doi.org/10.1038/s41386-021-01222-z

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.